| JYSZ2200027 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | License Renew | 2022-06-29 | | Pfizer Europe Ma Eeig;Wyeth Farma SA;Pfizer Investment Co Ltd | | | view |
| JYSB2500081 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2025-03-26 | | Bayer Healthcare LLC | | | view |
| JYSZ2200049 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | License Renew | 2022-09-14 | | Bayer Healthcare LLC;Bayer Healthcare Company Ltd | | | view |
| JYSB2400049 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2024-03-07 | | Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG | | | view |
| JYSB2200165 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-08-24 | | Bayer Healthcare LLC | | | view |
| JTS2400109 | 注射用培重组人凝血因子VIII | | Lyophilized | Biological Products | Disposable Import Drug Application | 2024-09-25 | | Baxalta Manufacturing Sàrl;Takeda Canada Inc;Takeda (China) International Trading Co Ltd | | | view |
| JXSS2200008 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(3.1) | Import Drug Application | 2022-01-26 | | Octapharma Ab Sweden;Sichuan Sinco Pharmaceutical Co Ltd | | | view |
| CYSB2400134 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(原10) | Supplementary Application | 2024-05-24 | | SinoCelltech Ltd | | | view |
| JYSB2101169 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2021-11-25 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | | | view |
| CYSB2400294 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(原10) | Supplementary Application | 2024-11-12 | | SinoCelltech Ltd | | | view |
| JYSB2101028 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2021-05-12 | | Bayer Healthcare LLC | | | view |
| JYSB2300036 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2023-02-23 | | Bayer Healthcare LLC | | | view |
| JYSB2101160 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2021-11-10 | | Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG | | | view |
| JYSB2400250 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2024-12-04 | | Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG | | | view |
| JXSS2200007 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(3.1) | Import Drug Application | 2022-01-26 | | Octapharma Ab Sweden;Sichuan Sinco Pharmaceutical Co Ltd | | | view |
| JYSB2300181 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2023-10-26 | | Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG | | | view |
| JYSB2200144 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-08-08 | | Bayer Healthcare LLC | | | view |
| JYSB1200216 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2012-08-27 | 拜耳医药保健有限公司 | Bayer Healthcare Company Ltd;Bayer Healthcare LLC | Approval Completed-Pending Certificated | | view |
| JYSB2400179 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2024-08-14 | | Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG | | | view |
| JXSS2200003 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(3.1) | Import Drug Application | 2022-01-26 | | Octapharma Ab Sweden;Sichuan Sinco Pharmaceutical Co Ltd | | | view |
